SCHEMBL20168137

SCHEMBL20168137

Fc1ccccc1-n1cc(Cn2ccc3c(Cl)ncnc32)cn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 1/20 0.46
FGFR4 P22455 1/20 0.46
DRD2 P14416 1/20 0.42
DRD4 P21917 1/20 0.42
DRD3 P35462 1/20 0.42
SCN9A Q15858 8/20 0.41
SCN5A Q14524 5/20 0.41
NOTUM Q6P988 1/20 0.39
GRM4 Q14833 1/20 0.38
KCNH2 Q12809 3/20 0.37
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TP53 P04637 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
BMPR1B O00238 1/20 0.35
ACVR1B P36896 1/20 0.35
TGFBR1 P36897 1/20 0.35
ACVRL1 P37023 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20182174 0.81 DRD2 (0.40) DRD2DRD4DRD3SCN9ASCN5A
SCHEMBL20162937 0.81 DRD2 (0.40) DRD2DRD4DRD3SCN9ASCN5A
SCHEMBL30037541 0.81 DRD2 (0.40) DRD2DRD4DRD3SCN9ASCN5A
SCHEMBL3541053 0.78 NOTUM (0.58) FGFR1FGFR4SCN9ASCN5ANOTUM
SCHEMBL29246282 0.75 FGFR1 (0.56) FGFR1FGFR4SCN9ASCN5ANOTUM
SCHEMBL30910343 0.75 FGFR1 (0.56) FGFR1FGFR4SCN9ASCN5ANOTUM
SCHEMBL31632925 0.73 PI4KA (0.47) FGFR1FGFR4KDM4EKMT2ATP53
SCHEMBL31632948 0.72 FGFR1 (0.53) FGFR1FGFR4SCN9ASCN5ANOTUM
SCHEMBL30910346 0.72 FGFR1 (0.59) FGFR1FGFR4SCN9ASCN5ANOTUM
SCHEMBL29246436 0.72 FGFR1 (0.59) FGFR1FGFR4SCN9ASCN5ANOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3541390-A1 PYRROLOPYRIMIDINES AS CFTR POTENTIATORS Cystic Fibrosis Foundation Therapeutics Inc. (US) 2019-09-25 EP disclosed
WO-2018094137-A1 PYRROLOPYRIMIDINES AS CFTR POTENTIATORS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC. (US) 2018-05-24 WO disclosed